Tonix Pharmaceuticals (TNXP) Misses Q3 EPS by 2c

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q3 EPS of ($0.71), $0.02 worse than the analyst estimate of ($0.69).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

You May Also Be Interested In

• Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance
• BNL commits $303 million to build Colorado tech facility
• Raymond James Resumes U.S. Bancorp (USB) at Strong Buy